On December 31, 2008, Novo Nordisk A-S (NVO) had a market capitalization of $22.8B, based on 6.21B shares at a price of $3.67.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2008 | $3.67 | 56,910,000 | 6,206,209,200 | $22,763,134,103.76 |
November 2008 | $3.65 | 51,120,000 | 6,206,209,200 | $22,635,286,194.24 |
October 2008 | $3.82 | 68,691,000 | 6,206,209,200 | $23,702,754,176.64 |
September 2008 | $3.65 | 64,812,000 | 6,186,000,000 | $22,605,499,800.00 |
August 2008 | $3.97 | 55,380,000 | 6,186,000,000 | $24,530,583,000.00 |
July 2008 | $4.53 | 45,062,000 | 6,186,000,000 | $28,040,519,400.00 |
June 2008 | $4.71 | 67,926,000 | 6,263,000,000 | $29,502,487,800.00 |
May 2008 | $4.66 | 30,405,000 | 6,263,000,000 | $29,189,337,800.00 |
April 2008 | $4.90 | 63,045,000 | 6,263,000,000 | $30,704,983,800.00 |
March 2008 | $4.94 | 55,422,000 | 6,264,367,800 | $30,957,879,230.82 |
February 2008 | $4.82 | 42,106,000 | 6,264,367,800 | $30,171,701,071.92 |
January 2008 | $4.42 | 45,487,000 | 6,264,367,800 | $27,691,637,859.90 |
December 2007 | $4.57 | 25,167,000 | 6,360,264,800 | $29,060,685,897.68 |
November 2007 | $4.49 | 20,000,000 | 6,360,264,800 | $28,549,956,634.24 |
October 2007 | $4.39 | 23,680,000 | 6,360,264,800 | $27,934,283,001.60 |
September 2007 | $4.26 | 24,056,000 | 6,363,557,900 | $27,130,392,750.86 |
August 2007 | $3.94 | 42,536,000 | 6,363,557,900 | $25,061,600,077.57 |
July 2007 | $3.70 | 32,190,000 | 6,363,557,900 | $23,514,619,152.08 |
June 2007 | $3.82 | 19,596,000 | 6,402,000,000 | $24,482,528,400.00 |
May 2007 | $3.71 | 24,830,000 | 6,402,000,000 | $23,729,013,000.00 |
April 2007 | $3.47 | 37,944,000 | 6,402,000,000 | $22,191,252,600.00 |
March 2007 | $3.19 | 28,480,000 | 6,393,375,100 | $20,386,555,181.37 |
February 2007 | $2.97 | 26,038,000 | 6,393,375,100 | $18,978,733,984.35 |
January 2007 | $2.98 | 22,530,000 | 6,393,375,100 | $19,049,700,447.96 |
December 2006 | $2.90 | 23,692,000 | 6,447,607,200 | $18,719,337,983.76 |
